StoneCrest Wealth Management »

Regeneron Pharmaceuticals shares owned by StoneCrest Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by StoneCrest Wealth Management from 13F filings

Historical chart of StoneCrest Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by StoneCrest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by StoneCrest Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $332k 316 1051.24
2024-06-30 $332k 316 1051.03
2024-03-31 $309k 321 962.49
2023-12-31 $285k 325 878.29

More positions owned by StoneCrest Wealth Management

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Putnam Etf Trust Focused Lar Cap (PVAL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
Vaneck Etf Trust Semiconductr Etf (SMH)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Meta Platforms Cl A (META)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Eli Lilly & Co. (LLY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Global X Fds S&p 500 Covered (XYLD)

View all positions for StoneCrest Wealth Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
T. Rowe Price Associates
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals